METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS
Therapeutic methods and pharmaceutical compositions for treating a myeloproliferative neoplasm (MPN), including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis, are described. In certain embodiments, the invention includes therapeutic methods of treating a MPN using a combi...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | Chinese English |
Published |
14.05.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Therapeutic methods and pharmaceutical compositions for treating a myeloproliferative neoplasm (MPN), including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis, are described. In certain embodiments, the invention includes therapeutic methods of treating a MPN using a combination of a compound of Formula (I) or Formula (II) with a therapeutic agent selected from the group consisting of a JAK inhibitor, an IDH inhibitor, a PD-1 inhibitor, a PD-L1 inhibitor, a PD-L2 inhibitor, an interferon, a PI3K inhibitor, an AKT inhibitor, an mTOR inhibitor, a nucleoside analog, and combinations thereof.
描述了用于治疗骨髓增殖性肿瘤(MPN),包括真性红细胞增多症(PV)、特发性血小板增多症(ET)和骨髓纤维化的治疗方法和药物组合物。在某些实施例中,本发明包括使用式(I)或式(II)的化合物与治疗剂的组合治疗MPN的治疗方法,所述治疗剂选自由JAK抑制剂、IDH抑制剂、PD-1抑制剂、PD-L1抑制剂、PD-L2抑制剂、干扰素、PI3K抑制剂、AKT抑制剂、mTOR抑制剂、核苷类似物及其组合组成的群组。 |
---|---|
Bibliography: | Application Number: CN201980049262 |